Form 4: Pressure BioSciences Director Acquires Additional Shares Through Interest Payment

Vito J. Mangiardi, a director at Pressure BioSciences Inc, acquired 625 shares of common stock on March 27, 2024, through interest paid on convertible preferred stock.

Summary

• On March 27, 2024, Vito J. Mangiardi, a director of Pressure BioSciences Inc (PBIO), acquired 625 shares of common stock.
• The acquisition was a result of interest paid in shares of common stock on convertible preferred stock.
• The price per share was $0.16.
• Following the transaction, Mangiardi directly owns 16,104 shares of PBIO common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction (interest payment in shares) and doesn't necessarily indicate a strong positive or negative outlook for the company.

Positives

• The director's acquisition of shares could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

This type of transaction, where interest on convertible securities is paid in shares, is relatively common, especially for smaller companies. It allows the company to conserve cash while still compensating investors.

Stakeholder Impact

• The transaction has a minor dilutive effect on existing shareholders due to the issuance of new shares.

Key Dates

Keywords

Pressure BioSciences Inc, PBIO, Vito J. Mangiardi, Director, Share Acquisition, Common Stock, Convertible Preferred Stock, Interest Payment, Beneficial Ownership, SEC Form 4